<DOC>
	<DOC>NCT01436253</DOC>
	<brief_summary>This study is being done to see whether dietary and medicinal measures compliant with hyperlipidemia treatment guidelines will result in achieving target lipid values and to evaluate the total risk of cardiovascular disease in study participants who have not reached satisfactory lipid levels with their current hypolipemic therapy.</brief_summary>
	<brief_title>Study of Lipid Control in Hyperlipidemic Participants (MK-0653-179)</brief_title>
	<detailed_description />
	<mesh_term>Dyslipidemias</mesh_term>
	<criteria>Inclusion criteria: Hyperlipidemic On therapy for hyperlipidemia for &gt;=3 months without achieving target lipid values Exclusion criteria: Hypersensitivity or intolerance to hypolipemics Significant myopathy or rhabdomiolysis probably caused by hypolipemics Uncontrolled endocrine or metabolic disease which is known to affect lipid or lipoprotein values (for example, hypothyroidism and hyperthyroidism)</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2015</verification_date>
</DOC>